Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pargellis

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|October 17, 2003
Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitorsRachel R Kroe, John Regan, Al Proto, et al.
Biochemical Pharmacology|December 13, 1996
Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminaseD D Jeanfavre, J R Woska, C A Pargellis, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Synthesis and SAR studies of indole-based MK2 inhibitorsZhaoming Xiong, Donghong Amy Gao, Derek A Cogan, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2008
Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinaseD A Cogan, R Aungst, E C Breinlinger, et al.
Nature Structural Biology|March 16, 2002
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding siteChristopher Pargellis, Liang Tong, Laurie Churchill, et al.
Biochemistry|August 4, 2004
Catalysis and function of the p38 alpha.MK2a signaling complexSusan M Lukas, Rachel R Kroe, Jessi Wildeson, et al.
Biochemistry|September 15, 2004
Discovery and characterization of a substrate selective p38alpha inhibitorWalter Davidson, Lee Frego, Gregory W Peet, et al.
Biochemical Pharmacology|November 26, 2008
Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signalingLore M Gruenbaum, Racheline Schwartz, Joseph R Woska, et al.
Journal of Medicinal Chemistry|June 28, 2002
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidateJohn Regan, Steffen Breitfelder, Pier Cirillo, et al.
British Journal of Haematology|December 19, 2006
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growthHiroshi Yasui, Teru Hideshima, Hiroshi Ikeda, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|October 17, 2003
Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitorsRachel R Kroe, John Regan, Al Proto, et al.
Biochemical Pharmacology|December 13, 1996
Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminaseD D Jeanfavre, J R Woska, C A Pargellis, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Synthesis and SAR studies of indole-based MK2 inhibitorsZhaoming Xiong, Donghong Amy Gao, Derek A Cogan, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2008
Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinaseD A Cogan, R Aungst, E C Breinlinger, et al.
Nature Structural Biology|March 16, 2002
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding siteChristopher Pargellis, Liang Tong, Laurie Churchill, et al.
Biochemistry|August 4, 2004
Catalysis and function of the p38 alpha.MK2a signaling complexSusan M Lukas, Rachel R Kroe, Jessi Wildeson, et al.
Biochemistry|September 15, 2004
Discovery and characterization of a substrate selective p38alpha inhibitorWalter Davidson, Lee Frego, Gregory W Peet, et al.
Biochemical Pharmacology|November 26, 2008
Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signalingLore M Gruenbaum, Racheline Schwartz, Joseph R Woska, et al.
Journal of Medicinal Chemistry|June 28, 2002
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidateJohn Regan, Steffen Breitfelder, Pier Cirillo, et al.
British Journal of Haematology|December 19, 2006
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growthHiroshi Yasui, Teru Hideshima, Hiroshi Ikeda, et al.
Pageof 4